Intervacc is trading 5.5% up at €0.07, with no clear company-specific catalyst identified for the October 2, 2026 move.

  • Its latest announcement said CEO Carl-Johan Dalsgaard would participate in the Swiss Nordic Bio Conference on October 1; it announced attendance, not a material business result or event.
  • Available market context shows no major same-direction index move explaining the gain, and the conference announcement alone does not establish causation.